Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Indonesia shares flu virus samples as crisis persists

This article was originally published in Clinica

Indonesia is again supplying the World Health Organization's network of collaborating centres with samples of H5N1 avian flu virus it had withheld since last August, the WHO has confirmed to the UK media.

Only last week, the WHO reaffirmed an agreement on the part of all member states to ensure that the healthcare-related and commercial benefits of sharing virus samples would be reciprocated with developing countries (see Clinica No 1295, p 15). According to The Guardian newspaper, however, the February 22 move was triggered by president Susilo Bambang Yudhoyono's reaction to accusations by health minister Siti Fadilah Supari that the US was misusing virus samples.

In May 2007, the WHO had announced that, despite the ongoing friction surrounding the issue, it had reached an agreement to resume virus sharing, while also enabling Indonesia to perform its own confirmatory testing (see Clinica No 1251, p 13). Indonesia had sought a legally-binding agreement by which samples could only be used for diagnostic and monitoring purposes.

Indonesia has a globally important role in monitoring avian flu, given the high incidence of the disease in poultry and the high number of human cases, thereby increasing the chances of a dangerous mutation.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT046232

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel